Literature DB >> 26820128

miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.

Bo Li1, Zhongshi Xie1, Bai Li2.   

Abstract

Accumulating evidence showed that microRNA-152 (miR-152) was frequently downregulated, and functioned as tumor suppressor in many cancers, but little is known about its biological role and intrinsic regulatory mechanisms in colorectal cancer (CRC). Here, we explored the potential role of miR-152 in CRC and the possible molecular mechanisms. Our results proved that miR-152 expression was downregulated in CRC cell lines and tissue samples, and its expression was inversely correlated with advanced tumor-node-metastasis (TNM) stage (P < 0.01) and lymph node metastasis (P < 0.01). Function assays demonstrated that restoring the expression of miR-152 in CRC cells dramatically reduced the cell proliferation and cell migration and invasion and promoted apoptosis and caspase-3 activity in vitro, as well as suppressed tumor growth in vivo. Mechanistic investigations defined phosphoinositide-3-kinase regulatory subunit 3 (PIK3R3) as a direct and functional downstream target of miR-152. In addition, we also found that PIK3R3 expression was upregulated and was inversely correlated with miR-152 expression in clinical CRC tissues. Downregulation of PIK3R3 mimicked the tumor-suppressive effects of miR-152 overexpression in CRC cells. Taken together, these results elucidated the function of miR-152 in CRC progression and suggested that miR-152 might function as tumor suppressor in CRC by targeting PIK3R3.

Entities:  

Keywords:  Colorectal cancer; MicroRNAs; PIK3R3; Tumor suppressor; miR-152

Mesh:

Substances:

Year:  2016        PMID: 26820128     DOI: 10.1007/s13277-016-4888-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  MiR-152 reduces human umbilical vein endothelial cell proliferation and migration by targeting ADAM17.

Authors:  Yang Wu; Aixue Huang; Tao Li; Xueting Su; Hongmei Ding; Hui Li; Xingliang Qin; Lubin Hou; Qiang Zhao; Xingfeng Ge; Tao Fang; Rong Wang; Changqing Gao; Jie Li; Ningsheng Shao
Journal:  FEBS Lett       Date:  2014-05-08       Impact factor: 4.124

Review 3.  MicroRNA function in cancer: oncogene or a tumor suppressor?

Authors:  Sylvia K Shenouda; Suresh K Alahari
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

4.  Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.

Authors:  Liliana Soroceanu; Samir Kharbanda; Ruihuan Chen; Robert H Soriano; Ken Aldape; Anjan Misra; Jiping Zha; William F Forrest; Janice M Nigro; Zora Modrusan; Burt G Feuerstein; Heidi S Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 5.  The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.

Authors:  Paulina Tokarz; Janusz Blasiak
Journal:  Acta Biochim Pol       Date:  2012-11-21       Impact factor: 2.149

6.  PIK3R3 induces epithelial-to-mesenchymal transition and promotes metastasis in colorectal cancer.

Authors:  Guihua Wang; Xi Yang; Chuan Li; Xiaonian Cao; Xuelai Luo; Junbo Hu
Journal:  Mol Cancer Ther       Date:  2014-05-16       Impact factor: 6.261

7.  Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.

Authors:  Xin Zhou; Fang Zhao; Zhen-Ning Wang; Yong-Xi Song; Hua Chang; Yeunpo Chiang; Hui-Mian Xu
Journal:  Oncol Rep       Date:  2011-10-03       Impact factor: 3.906

8.  miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells.

Authors:  Hantao Wang; Fuao Cao; Xu Li; Hua Miao; Jifu E; Junjie Xing; Chuan-Gang Fu
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

9.  MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2.

Authors:  Zhenshun Cheng; Rongli Ma; Weijun Tan; Li Zhang
Journal:  Exp Mol Med       Date:  2014-09-05       Impact factor: 8.718

10.  miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2.

Authors:  L Sheng; P He; X Yang; M Zhou; Q Feng
Journal:  Cell Death Dis       Date:  2015-07-09       Impact factor: 8.469

View more
  23 in total

1.  MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.

Authors:  Melanie Rammer; Gerald Webersinke; Sophie Haitchi-Petnehazy; Eva Maier; Hubert Hackl; Pornpimol Charoentong; Theodora Malli; Maria Steinmair; Andreas L Petzer; Holger Rumpold
Journal:  Clin Exp Metastasis       Date:  2017-11-13       Impact factor: 5.150

2.  MicroRNA-152 inhibits ovarian cancer cell proliferation and migration and may infer improved outcomes in ovarian cancer through targeting FOXP1.

Authors:  Wen Qin; Wei Xie; Qinglin He; Tianwei Sun; Chaoguo Meng; Kunling Yang; Yuanfu Luo; Dongmei Yang
Journal:  Exp Ther Med       Date:  2017-11-17       Impact factor: 2.447

3.  LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.

Authors:  Shouhua Zhang; Juhua Xiao; Yong Chai; Yun Yan Du; Zhiqiang Liu; Kai Huang; Xin Zhou; Wei Zhou
Journal:  Dig Dis Sci       Date:  2017-09-18       Impact factor: 3.199

4.  Long Noncoding RNA PVT1 Acts as a "Sponge" to Inhibit microRNA-152 in Gastric Cancer Cells.

Authors:  Ting Li; Xiang-Ling Meng; Wen-Qi Yang
Journal:  Dig Dis Sci       Date:  2017-03-03       Impact factor: 3.199

Review 5.  The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer.

Authors:  Clément Lecerf; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Cell Mol Life Sci       Date:  2019-07-23       Impact factor: 9.261

Review 6.  Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer.

Authors:  Dan-Dan Zhou; Xiu-Fen Liu; Cheng-Wei Lu; Om Prakash Pant; Xiao-Dong Liu
Journal:  Cell Prolif       Date:  2017-10-12       Impact factor: 6.831

7.  MicroRNA-613 targets FMNL2 and suppresses progression of colorectal cancer.

Authors:  Bai Li; Zhongshi Xie; Zhihong Li; Si Chen; Bo Li
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

8.  Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated colon cancer.

Authors:  Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Xiaorong Zhu; Dilip Deb; Stephen C Meredith; Fatma Ayaloglu-Butun; Michelle Fletcher; Arantxa Sanchez; Joel Pekow; Zifeng Deng; Nader Amini; Vani J Konda; Vijaya L Rao; Atsushi Sakuraba; Akushika Kwesi; Sonia S Kupfer; Alessandro Fichera; Loren Joseph; John Hart; Fang He; Tong-Chuan He; Diana West-Szymanski; Yan Chun Li; Marc Bissonnette
Journal:  Epigenetics       Date:  2020-12-28       Impact factor: 4.528

Review 9.  HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development.

Authors:  Devis Pascut; Minh Hoang; Nhu N Q Nguyen; Muhammad Yogi Pratama; Claudio Tiribelli
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

10.  miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells.

Authors:  Bai Li; Liang Ge; Minghe Li; Lei Wang; Zhihong Li
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.